Senseonics Holdings Inc (SENS)
0.435
-0.01
(-2.03%)
USD |
NYAM |
May 28, 16:00
0.4336
0.00 (0.00%)
After-Hours: 20:00
Senseonics Holdings Cash from Financing (Quarterly): 10.03M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.03M |
| December 31, 2023 | -1.178M |
| September 30, 2023 | 16.82M |
| June 30, 2023 | 5.526M |
| March 31, 2023 | -0.807M |
| December 31, 2022 | 10.35M |
| September 30, 2022 | 27.22M |
| June 30, 2022 | -1.846M |
| March 31, 2022 | 6.043M |
| December 31, 2021 | -7.191M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 50.60M |
| March 31, 2021 | 176.67M |
| December 31, 2020 | 0.061M |
| September 30, 2020 | 18.20M |
| June 30, 2020 | 19.60M |
| March 31, 2020 | -47.98M |
| December 31, 2019 | 0.013M |
| September 30, 2019 | 101.13M |
| Date | Value |
|---|---|
| June 30, 2019 | -2.43M |
| March 31, 2019 | -2.476M |
| December 31, 2018 | -2.259M |
| September 30, 2018 | -1.659M |
| June 30, 2018 | 146.84M |
| March 31, 2018 | 49.06M |
| December 31, 2017 | 0.018M |
| September 30, 2017 | 26.56M |
| June 30, 2017 | 40.41M |
| March 31, 2017 | 5.077M |
| December 31, 2016 | 4.912M |
| September 30, 2016 | -0.008M |
| June 30, 2016 | 9.10M |
| March 31, 2016 | 40.89M |
| September 30, 2015 | 0.009M |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.015M |
| September 30, 2014 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-47.98M
Minimum
Mar 2020
176.67M
Maximum
Mar 2021
19.04M
Average
5.784M
Median
Cash from Financing (Quarterly) Benchmarks
| Stereotaxis Inc | 0.03M |
| Biolase Inc | 5.647M |
| AVITA Medical Inc | 0.631M |
| Perspective Therapeutics Inc | 166.33M |
| Electromed Inc | 0.056M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.26M |
| Cash from Investing (Quarterly) | 25.38M |
| Free Cash Flow | -71.19M |
| Free Cash Flow Per Share (Quarterly) | -0.0335 |
| Free Cash Flow to Equity (Quarterly) | -31.28M |
| Free Cash Flow Yield | -27.41% |